Literature DB >> 11163865

Susceptibility to Leishmania major infection in the absence of IL-4.

N Noben-Trauth1.   

Abstract

Infection with the intracellular parasite Leishmania major is the prototypical model system used to study Th1 and Th2 cytokine responses in vivo. Mouse strains that are resistant to L. major produce high levels of IFNgamma, and Th1 cytokines while susceptible BALB/c mice have elevated levels of IL-4, and Th2-associated cytokines during infection. While antibody neutralization of IL-4 or IFNgamma in vivo alters the disease patterns, infection of mice genetically deficient for IL-4 or IL-4 receptor (IL-4Ralpha) yield surprising outcomes. Contrary to the Th1/Th2 paradigm, IL-4- / - and IL-4Ralpha -/ - mice remain highly susceptible to L. major parasite substrain LV39. In distinct contrast, another L. major substrain. IR173, the IL-4Ralpha - / -mice are highly resistant. These findings indicate a disparity between antibody treatment versus gene deletion, and more generally, challenge the role of IL-4 in promoting susceptibility to L. major. Furthermore, IL-4Ralpha - / - mice reveal that the ability of L. major to escape immune clearance depends on the parasite substrain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163865     DOI: 10.1016/s0165-2478(00)00280-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.

Authors:  Joseph Barbi; Frank Brombacher; Abhay R Satoskar
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.

Authors:  Thierry Lang; Nathalie Courret; Jean-Hervé Colle; Geneviève Milon; Jean-Claude Antoine
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.

Authors:  Laura Ramírez; Salvador Iborra; Jimena Cortés; Pedro Bonay; Carlos Alonso; Manoel Barral-Netto; Manuel Soto
Journal:  J Biomed Biotechnol       Date:  2010-01-26

4.  Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner.

Authors:  Michael J Donovan; Britta Z Maciuba; Caitlin E Mahan; Mary Ann McDowell
Journal:  Exp Parasitol       Date:  2009-06-03       Impact factor: 2.011

Review 5.  Potential biomarkers of immune protection in human leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Ali Khamesipour
Journal:  Med Microbiol Immunol       Date:  2021-05-02       Impact factor: 3.402

6.  Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis.

Authors:  Alireza Ahmadi; Mehrdad Hajilooi; Ghasem Solgi; Mohammad Abasi; Ahad Bazmani; Mohammad Matini; Khosro Sardarian
Journal:  Adv Biomed Res       Date:  2015-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.